Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial

Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial

Abstract Background Measles is a highly contagious and serious infection. Before the introduction of vaccination, measles caused yearly epidemics putting vulnerable children at risk of brain damage and death. Despite safe and cost-effective vaccines, measles remains a leading cause of death in child...

Full description

Bibliographic Details
Main Authors: Dorthe Maria Vittrup, Anne Cathrine Lund Laursen, Michelle Malon, Jesper Kiehn Soerensen, Jakob Hjort, Soren Buus, Jannet Svensson, Lone Graff Stensballe
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Trials
Subjects:
Measles
MMR
Vaccinology
Immunogenicity
Indirect effects of vaccines
Vaccine efficacy
Online Access:https://doi.org/10.1186/s13063-020-04845-7

Internet

https://doi.org/10.1186/s13063-020-04845-7

Similar Items